WRF
AERI

Waddell & Reed Financial’s Aerie Pharmaceuticals AERI Stock Holding History

Waddell & Reed Financial’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-902,580
Closed -$21.8M – 491
2019
Q4 		$21.8M Sell
902,580
-977,845
-52% -$20.3M 0.05% 337
2019
Q3 		$36.1M Buy
1,880,425
+142,798
+8% +$3.27M 0.09% 238
2019
Q2 		$51.3M Buy
1,737,627
+224,655
+15% +$8.66M 0.13% 200
2019
Q1 		$71.9M Buy
1,512,972
+60,124
+4% +$2.65M 0.18% 156
2018
Q4 		$52.4M Buy
1,452,848
+743,808
+105% +$34.9M 0.15% 185
2018
Q3 		$43.6M Buy
709,040
+248,323
+54% +$16M 0.1% 243
2018
Q2 		$31.1M Buy
460,717
+7,170
+2% +$401K 0.07% 283
2018
Q1 		$24.6M Sell
453,547
-1,880
-0.4% -$105K 0.06% 304
2017
Q4 		$27.2M Sell
455,427
-7,927
-2% -$481K 0.06% 294
2017
Q3 		$22.5M Buy
463,354
+271,254
+141% +$14.8M 0.05% 314
2017
Q2 		$10.1M Hold
192,100
– – 0.02% 421
2017
Q1 		$8.71M Hold
192,100
– – 0.02% 447
2016
Q4 		$7.27M Hold
192,100
– – 0.02% 461
2016
Q3 		$7.25M Buy
192,100
+4,400
+2% +$97K 0.02% 444
2016
Q2 		$3.3M Hold
187,700
– – 0.01% 532
2016
Q1 		$2.28M Buy
187,700
+3,100
+2% +$49K ﹤0.01% 570
2015
Q4 		$4.5M Hold
184,600
– – 0.01% 500
2015
Q3 		$3.27M Buy
+184,600
New +$3.34M 0.01% 542

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Waddell & Reed Financial's AERI Position: Q1 2020 in Review

Waddell & Reed Financial sold out of Aerie Pharmaceuticals (AERI) in Q1 2020, closing a stake of 902,580 shares — an estimated $21.8M sold.

Waddell & Reed Financial first reported a position in AERI in Q3 2015 and held it in 18 quarters. The position peaked at $71.9M in Q1 2019. 155 funds tracked by Wall St. Rank hold AERI as of Q1 2020.

  • Waddell & Reed Financial reported no remaining Aerie Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Waddell & Reed Financial sold 902,580 Aerie Pharmaceuticals shares in Q1 2020, an estimated $21.8M.
  • Waddell & Reed Financial first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 18 quarters.
  • Waddell & Reed Financial's Aerie Pharmaceuticals position peaked at $71.9M in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2020.

Based on Waddell & Reed Financial's 13F filing for Q1 2020, filed 15 May 2020.